Munib adjusts your protocol based on how you respond and your ongoing symptoms
Buse JB, Sesti G, Schmidt WE, et al
Food and Drug Administration (FDA) approved Eli Lilly and Companys Zepbound (tirzepatide), an obesity medication, for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity
The Outsourcing Facilities Association filed a lawsuit against the FDA on February 24, 2025, challenging the determination that the semaglutide shortage had been resolved
Yes, many women report enhanced clarity and memory after postpartum brain changesthough always consult your provider before starting
If you've tried GLP-1 drugs and stopped because of side effects or cost, know that the landscape is changing faster than most people realize